相关实验视频
Updated: Sep 20, 2025

09:30
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
Published on: December 18, 2016
19.7K
在CKD中对骨肌肉进行多参数定量磁共振成像
Noah Markewitz1, Can Wu2, Moriel Vandsburger3
1Department of Medicine, Albert Einstein College of Medicine, New York City, New York, United States.
American journal of physiology. Renal physiology
|May 27, 2025
概括
定量MRI检测慢性病 (CKD) 患者在功能衰退之前的骨肌肉变化. 这种非侵入性成像揭示了纤维化,脂肪透和代谢问题,为活检提供了替代方案.
科学领域:
- 生物医学成像技术 生物医学成像技术
- 腎臟病學 (nephrology) 是一種醫學.
- 肌肉骨系统 运动骨系统
背景情况:
- 骨肌肉功能障碍是慢性病 (CKD) 中残疾的主要原因.
- 早期识别肌肉病理对于在显著功能损失之前进行干预至关重要.
- 目前的方法,如肌肉活检是侵入性的,可能无法捕捉病理的全部程度.
研究的目的:
- 研究多参数定量磁共振成像 (qMRI) 对于检测CKD患者骨肌病理的有用性.
- 为了比较慢性病4-5期,末期病 (ESKD) 和健康对照的qMRI发现.
- 评估有关纤维化,脂肪透和骨肌肉代谢变化的qMRI指标.
主要方法:
- 在6名CKD (阶段4-5),3名ESKD和10名健康对照参与者的7个腿部肌肉组上使用3台特斯拉MRI扫描仪进行了多参数QMRI.
- 测量包括旋转框架中的T1放松时间 (T1ρ) 和T2映射,脂肪分数的迪克森成像 (FF),扩散张力成像 (DTI) 和脂质和代谢物的1H-MR光谱.
- 分析的重点是跨组T1ρ,T2,FF,DTI参数,细胞内和细胞外脂质 (IMCL/EMCL),三甲基胺和肌酸度的差异.
主要成果:
- 与对照组相比,患有CKD的患者表现出延长的T1ρ和T2时间,以及较高的FF.
- 内肌细胞脂质 (IMCL) 较高,而三甲基胺和肌酸度在CKD患者和对照人群中较低.
- 在所有肌肉群中,T1ρ和FF均相似升高;与CKD患者相比,ESKD患者的T1ρ和T2较低,类似于对照组.
结论:
- 多参数QMRI可非侵入性地识别CKD患者的骨肌肉纤维化,脂肪透和代谢失调.
- 在实质性的身体功能下降发生之前,qMRI指标可以检测肌肉病理.
- 这种定量成像方法为评估CKD肌肉健康提供了传统肌肉活检的有价值,非侵入性的替代方案.
相关概念视频
Imaging Studies IV: Magnetic Resonance Imaging
60
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
60
Magnetic Resonance Imaging
7.3K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.3K
Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
Imaging Studies I: Kidney, Ureter, and Bladder Studies
48
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
48
Chronic Kidney Disease I: Introduction
78
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
78

